Results 41 to 50 of about 163,785 (367)
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu+8 more
doaj +1 more source
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Background: The human heart primarily metabolizes fatty acids, and this decreases as alternative fuel use rises in heart failure with reduced ejection fraction (HFrEF).
V. Hahn+12 more
semanticscholar +1 more source
Heart failure with preserved ejection fraction (HFpEF) represents a highly heterogeneous clinical syndrome affected in its development and progression by many comorbidities.
S. Anker+38 more
semanticscholar +1 more source
Biomarkers in heart failure with preserved ejection fraction [PDF]
Biomarkers are widely used and studied in heart failure. Most studies have described the utility and performance of biomarkers in sub-studies of randomised clinical trials, where the vast majority of the patients suffered from heart failure with reduced ejection fraction (HFrEF), and not with preserved ejection fraction (HFpEF). As a result, there is a
A. R. Van der Velde+2 more
openaire +3 more sources
Background: Clinical characteristics of patients with heart failure may vary geographically. However, limited data are available regarding the geographical differences of patients with heart failure and preserved ejection fraction.
Bülent Özlek+19 more
doaj +1 more source
Heart Failure With Preserved Ejection Fraction in the Young [PDF]
Background: Heart failure with preserved ejection fraction (HFpEF), traditionally considered a disease of the elderly, may also affect younger patients. However, little is known about HFpEF in the young. Methods: We prospectively enrolled 1203 patients with HFpEF (left ventricular ...
Lieng H. Ling+16 more
openaire +6 more sources
Heart failure with preserved ejection fraction and diabetes mellitus [PDF]
Heart failure with preserved ejection fraction (HFpEF) constitutes approximately 50% of heart failure patients. The prevalence of diabetes mellitus in HFpEF is high at 30-40%.
Cassar, Andrew+3 more
core +1 more source
Aims The PARAGLIDE-HF trial demonstrated reductions in natriuretic peptides with sacubitril/valsartan compared with valsartan in patients with heart failure (HF) with mildly reduced or preserved ejection fraction who had a recent worsening HF event, but ...
M. Vaduganathan+16 more
semanticscholar +1 more source
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart ...
A. A. Borisov+2 more
doaj +1 more source
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. [PDF]
BACKGROUND: Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. We compared the effect of isosorbide mononitrate or placebo on daily activity in such patients.
Anstrom, Kevin J.+18 more
core +2 more sources